Albany, NY -- (SBWire) -- 11/22/2018 --D-dimer Testing Market: Overview
At present, the in vitro diagnostics market is one of the fastest growing markets globally. This remarkable growth can be attributed to the improved health care awareness, preference of the people for preventive health checkups, accessibility to disease specific tests, and shift from manual to semi-automated and automated instruments. Diagnostic laboratories are facing challenges in delivering high-quality, efficient and timely testing solutions due to rising health care awareness and stringent regulations that put pressure on the health care budgets.
This has led to growing adoption of automated solutions and new analyzers that deliver high throughput in lesser time and with enhanced efficiency. Point-of care testing has gained momentum in the past few years to meet the demand for quick turnaround time, thus accelerating reliable results. D-dimer assays and POC kits have been developed to confirm the exclusion of deep vein thrombosis (DVT), pulmonary embolism (PE), and disseminated intravascular coagulation (DIC).
D-dimer Testing Market: Segmentation
The D-dimer testing market has been extensively analyzed on the basis of testing methods, applications, and geography. Testing methods include point-of-care testing (POC) and laboratory testing. Laboratory testing has been further segmented into coagulation analyzers and clinical chemistry analyzers. Applications comprise deep vein thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC) and others.
Each of the segments has been analyzed in detail for market trends, number of D-dimer tests, recent developments, outlook, and opportunities. The report provides current and future market size for each segment and sub-segment for the period from 2017 to 2025, in terms of revenue in USD million and number of tests in million, considering 2015 and 2016 as the base years. The compound annual growth rate (%CAGR) for each market segment has been provided for the forecast period from 2017 to 2025 along with the estimations of market size.
Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2398
Geographically, the global D-dimer testing market has been classified into five major geographical regions: North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. The regions have been further segmented by major countries. The current and future market sizes in terms of revenue (USD million) and number of tests (million) of these regional markets and their major countries have been provided in the report for the period from 2015 to 2025, with their growth rate (%) for the period from 2017 to 2025. The study also offers a list of recommendations and highlights of the market for new companies willing to enter the market and for existing companies to increase market shares, which is likely to help in the decision-making process.
The market overview section of the report demonstrates the market dynamics and market trends such as drivers, restraints, opportunities and key trends that influence the current and future status of the D-dimer industry. The report also covers market attractiveness analysis, Porter's Five Forces analysis and key market share analysis in the market overview section, in order to give a thorough analysis of the overall competitive scenario in the global D-dimer testing market.
Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2398
The report concludes with the company profiles section that includes key information about the major players in the market. Key players profiled in this report include Abbott Laboratories, Beckman Coulter, Inc., Bio/Data Corporation, Becton, Dickinson and Company, Grifols, S.A., F. Hoffman-La Roche Ltd., Helena Biosciences, Siemens Healthcare, Sysmex Corporation, and Thermo Fisher Scientific. Each of these players is profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio, and recent developments.
More Trending Reports by Transparency Market Research –
Implantable Medical Devices Market: https://www.prnewswire.com/news-releases/implantable-medical-devices-market-predicted-to-be-worth-us-49-8-bn-by-2024-says-tmr-894467337.html
Rheumatoid Arthritis Drugs Market: http://www.prnewswire.co.uk/news-releases/rheumatoid-arthritis-drugs-market-to-be-worth-us-267586-mn-by-2026-says-tmr-689965851.html
About Transparency Market Research
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com
D-Dimer Testing Market to Register CAGR of over 4.0% from 2017 to 2025